Survival of penetrating keratoplasty: a claims-based longitudinal analysis.


Journal

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
ISSN: 1715-3360
Titre abrégé: Can J Ophthalmol
Pays: England
ID NLM: 0045312

Informations de publication

Date de publication:
02 2021
Historique:
received: 17 04 2020
revised: 10 07 2020
accepted: 24 07 2020
pubmed: 7 9 2020
medline: 19 8 2021
entrez: 6 9 2020
Statut: ppublish

Résumé

To report real-world long-term survival of primary penetrating keratoplasty (PK) in the United States and analyze risk factors associated with failure. Retrospective longitudinal cohort study using a large commercial insurance database. Ten million patients enrolled in the database from 2011 to 2017 were identified using Current Procedural Terminology codes for PK. Kaplan-Meier survival analysis was performed to determine failure rate and risk factors impacting graft outcomes. Five hundred and ninety-six primary PKs were identified. The 3-year survival was 78% (confidence interval [CI]: 73%-82%), 5-year survival was 76% (CI: 70%-80%), and 7-year survival was 73% (CI: 66%-79%). This study demonstrated a significantly lower 5-year success rate for primary PK performed for all causes than previously published case series in the United States.

Identifiants

pubmed: 32891566
pii: S0008-4182(20)30705-5
doi: 10.1016/j.jcjo.2020.07.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-16

Informations de copyright

Copyright © 2020 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Sumayya Ahmad (S)

Icahn School of Medicine of Mount Sinai, New York, NY. Electronic address: sumayya.ahmad@mountsinai.org.

Janek Klawe (J)

Icahn School of Medicine of Mount Sinai, New York, NY; Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey; The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD; W. L. Gore and Associates, Flagstaff, AZ.

Canan Asli Utine (CA)

Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.

Divya Srikumaran (D)

The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD.

Jose Jimenez (J)

W. L. Gore and Associates, Flagstaff, AZ.

Esen Akpek (E)

The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH